Biopharmaceutical firm Icoria has received another patent as part of its drug and chemical research technology.

The latest patent protects identification of certain gene inhibitors for use as antibiotics. It covers “the discovery of a novel gene target for antibiotic development in a biochemical pathway by which fungi produce asparagine, a nutrient necessary for fungal growth,” Icoria said in a statement. “The patent also covers methods enabling the discovery of chemicals that inhibit protein target activities within this critical pathway. These methods potentially increase the probability that fungicides could be found that affect this pathway.”

Icoria has filed for 37 patents related to fungicide gene targets since 2001 and has now received seven.